The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis

被引:22
作者
Moriguchi, Kota [1 ,2 ]
Miyamoto, Katsuichi [3 ]
Tanaka, Noriko [3 ]
Yoshie, Osamu [4 ]
Kusunoki, Susumu [3 ]
机构
[1] Natl Def Med Coll, Dept Internal Med 3, Div Neurol, Tokorozawa, Saitama 359, Japan
[2] Japan Ground Self Def Force, Middle Army Med Unit, Itami, Hyogo, Japan
[3] Kinki Univ, Sch Med, Dept Neurol, Osaka 5898511, Japan
[4] Kinki Univ, Sch Med, Dept Microbiol, Osaka 5898511, Japan
关键词
Experimental autoimmune encephalomyelitis; Chemokine receptor; Th17; CCR6; CCR4; T-CELLS; MULTIPLE-SCLEROSIS; EAE; TARGET;
D O I
10.1016/j.jneuroim.2013.02.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokine receptors (CCRs) play important roles in the pathogenesis of immune-mediated diseases, as well as in normal immune response. We examined the role of CCR6 and CCR4 in experimental autoimmune encephalomyelitis (EAE) by using CCR6(-/-)CCR4(-/-) double knockout (DKO) and single knockout mice. DKO mice developed less severe EAE and presented repressed recall response in the induction phase, especially in the activity of T helper 17 (Th17) cells. CCR6 expression in central nervous system (CNS)-infiltrated cells was diminished in DKO. Our results suggest that CCR6 and CCR4 were involved in a more rapid progression of EAE and that their regulation might be a therapeutic target of human inflammatory demyelinating diseases. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 19 条
  • [1] Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro
    Ambrosini, E
    Columba-Cabezas, S
    Serafini, B
    Muscella, A
    Aloisi, F
    [J]. GLIA, 2003, 41 (03) : 290 - 300
  • [2] Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159
  • [3] Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination
    Buschmann, J. P.
    Berger, K.
    Awad, H.
    Clarner, T.
    Beyer, C.
    Kipp, M.
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 66 - 76
  • [4] Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
    Domingues, Helena S.
    Mues, Marsilius
    Lassmann, Hans
    Wekerle, Hartmut
    Krishnamoorthy, Gurumoorthy
    [J]. PLOS ONE, 2010, 5 (11):
  • [5] Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis
    Elhofy, Adam
    DePaolo, R. William
    Lira, Sergio A.
    Lukacs, Nicholas W.
    Karpus, William J.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 213 (1-2) : 91 - 99
  • [6] Ferber IA, 1996, J IMMUNOL, V156, P5
  • [7] Forde E.A., 2011, J NEUROIMMUNOL
  • [8] CCR4 as a novel molecular target for immunotherapy of cancer
    Ishida, Takashi
    Ueda, Ryuzo
    [J]. CANCER SCIENCE, 2006, 97 (11) : 1139 - 1146
  • [9] MIP-1 alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphoctye differentiation
    Karpus, WJ
    Kennedy, KJ
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (05) : 681 - 687
  • [10] Koelink P.J., 2011, PHARM THER